Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ISRG | Common Stock | Options Exercise | $1.31M | +22.1K | +14.3% | $59.23 | 176K | Feb 7, 2024 | Direct | F1 |
transaction | ISRG | Common Stock | Sale | -$5.02M | -12.9K | -7.32% | $389.29 | 163K | Feb 7, 2024 | Direct | F1, F2 |
transaction | ISRG | Common Stock | Options Exercise | $1.26M | +22.1K | +13.49% | $57.11 | 185K | Feb 7, 2024 | Direct | F1 |
transaction | ISRG | Common Stock | Sale | -$5M | -12.8K | -6.92% | $389.30 | 173K | Feb 7, 2024 | Direct | F1, F3 |
transaction | ISRG | Common Stock | Options Exercise | $1.43M | +28.1K | +16.29% | $51.02 | 201K | Feb 7, 2024 | Direct | F1 |
transaction | ISRG | Common Stock | Sale | -$6.29M | -16.2K | -8.05% | $389.23 | 185K | Feb 7, 2024 | Direct | F1, F4 |
transaction | ISRG | Common Stock | Options Exercise | $1.99M | +40.5K | +21.94% | $49.09 | 225K | Feb 7, 2024 | Direct | F1 |
transaction | ISRG | Common Stock | Sale | -$9M | -23.1K | -10.27% | $389.28 | 202K | Feb 7, 2024 | Direct | F1, F5 |
transaction | ISRG | Common Stock | Options Exercise | $1.39M | +28.1K | +13.93% | $49.34 | 230K | Feb 7, 2024 | Direct | F1 |
transaction | ISRG | Common Stock | Sale | -$6.11M | -15.7K | -6.82% | $389.29 | 214K | Feb 7, 2024 | Direct | F1, F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -40.5K | -100% | $0.00* | 0 | Feb 7, 2024 | Common Stock | 40.5K | $49.09 | Direct | F1, F7 |
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -28.1K | -100% | $0.00* | 0 | Feb 7, 2024 | Common Stock | 28.1K | $49.34 | Direct | F1, F7 |
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -28.1K | -100% | $0.00* | 0 | Feb 7, 2024 | Common Stock | 28.1K | $51.02 | Direct | F1, F8 |
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -22.1K | -100% | $0.00* | 0 | Feb 7, 2024 | Common Stock | 22.1K | $57.11 | Direct | F1, F7 |
transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -22.1K | -100% | $0.00* | 0 | Feb 7, 2024 | Common Stock | 22.1K | $59.23 | Direct | F1, F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2025. |
F2 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,000 shares sold at $386.61 to $387.54; 2,050 shares sold at $387.70 to $388.67; 6,109 shares sold at $388.80 to $389.76; 3,201 shares sold at $389.84 to $390.61; and 540 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F3 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,100 shares sold at $386.61 to $387.54; 1,900 shares sold at $387.70 to $388.67; 5,974 shares sold at $388.80 to $389.75; 3,526 shares sold at $389.84 to $390.79; and 340 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F4 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,712 shares sold at $386.61 to $387.37; 2,350 shares sold at $387.70 to $388.42; 7,354 shares sold at $388.80 to $389.77; 4,094 shares sold at $389.84 to $390.73; and 640 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F5 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $392.00 as follows: 2,057 shares sold at $386.61 to $387.37; 3,377 shares sold at $387.70 to $388.69; 10,942 shares sold at $388.77 to $389.77; 5,904 shares sold at $389.79 to $390.79; 740 shares sold at $390.91 to $391.57; and 100 shares sold at $392.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F6 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57as follows: 1,300 shares sold at $386.61 to $387.54; 2,400 shares sold at $387.70 to $388.67; 7,622 shares sold at $388.77 to $389.75; 3,938 shares sold at $389.84 to $390.79; and 440 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F7 | Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
F8 | Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |